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Letters
Non-O157 Shiga Toxin–Producing
Escherichia coli Infections in Europe
To the Editor: Shiga toxin–producing Escherichia
coli (STEC) infections are an important cause of
severe human disease. Although most infections
are caused by strains of serogroup O157, STEC
pathogenic to humans may belong to other
serogroups usually referred to as non-O157 STEC.
Recently, Tarr et al. (1) and Acheson et al. (2)
described infections attributable to STEC O103
and expressed concern that non-O157 STEC may
pose an underestimated threat to public health in
the United States. In fact, non-O157 STEC is
often overlooked in clinical microbiology labora-
tories because the toxigenic phenotype is not
exploited to identify such pathogens. Rather,
most laboratories use sorbitol MacConkey agar
and serotyping (which cannot detect most non-
O157 STEC) to identify E. coli O157:H7.
Since the end of the 1980s, non-O157 STEC
infections have caused as many as 10% to 30% of
sporadic cases of hemolytic uremic syndrome
(HUS) in Germany (3), Italy (4), and the United
Kingdom (5). Moreover, HUS outbreaks have
been associated with STEC O111:H- in Italy (6)
and France (7).
During 1996, we observed a sudden increase
in infections attributable to STEC O103 and O26
in Germany and Italy. In our laboratory in
Germany, E. coli O103:H2 was not identified
among 345 non-O157 STEC isolated between
1985 and 1995 but represented 12 (18.2%) of 66 of
the non-O157 STEC isolated during 1996. HUS
developed in two infected patients.
Among cases reported to Italy’s nationwide
HUS surveillance system from 1988 to 1995,
evidence of infection with STEC O103 or O26 was
found in two (1.5%) and nine (6.6%) of 135 cases,
respectively. Since 1996, infection with STEC
O103 and O26 has been diagnosed in three (11%)
and nine (33%) of 27 HUS cases, respectively.
These observations indicate that identifica-
tion of non-O157 STEC should be considered by
clinical laboratories. Immunoenzymatic tests
(based on either toxin antibodies or receptors)
that detect Shiga toxins produced by fecal
bacterial isolates or present in stool specimens
are now available (8,9). Use of these tests should
be considered in analyzing the stools of patients
with HUS, bloody diarrhea, or painful nonbloody
diarrhea, if classic microbiologic analysis fails to
yield  E. coli O157:H7 or another standard
enteric pathogen, such as Campylobacter,
Salmonella, or Shigella.
The sudden appearance or increase of rare
non-O157 STEC in our populations is worrisome.
Most non-O157 STEC, as well as the sorbitol
fermenting O157:H- strains (10) associated
with HUS in several European countries,
would be missed by laboratories using standard
microbiologic detection methods, such as
sorbitol MacConkey agar screening. Because of
the considerable clinical and epidemiologic
urgency, clinical microbiologists and physi-
cians should seek out these such pathogens in
appropriate clinical situations.
Alfredo Caprioli,* Alberto E. Tozzi,*
Gianfranco Rizzoni,† and Helge Karch‡
*Istituto Superiore di Sanità, Rome, Italy;
†Ospedale Pediatrico Bambino Gesù, Rome, Italy;
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The Taxonomy of Cyclospora
To the Editor: In the article by N.J. Pieniazek and
B.L. Herwaldt (1) on the rRNA gene of Cyclospora
cayetanensis, the authors suggest that Cyclospora
should be placed in the genus Eimeria because
the rRNA genes of the two genera have similar
sequences. The article refers to Norman D.
Levine’s chapter on the Apicomplexa in the
Illustrated Guide to the Protozoa (2). Regretta-
bly, the authors failed to read the whole chapter
and to recognize that the initial characteristics
for placing the oocyst of a coccidium in its proper
genus are the number of sporocysts and then the
number of sporozoites in each sporocyst. The
genus Eimeria has four sporocysts and two
sporozoites in each sporocyst. The genus
Cyclospora has two sporocysts, each of which has
two sporozoites.
The original taxonomists (3) of C. cayetanensis
recognized that it should be placed in the
taxonomic family Eimeriidae, close to Eimeria,
but they adhered to the traditional designation
for genera of coccidia. Pieniazek and Herwaldt
should be cognizant of the rules of zoologic
nomenclature as well as the fact that certain
morphologic characteristics of protists have
served us well for many decades and continue to
be useful. There are serious consequences to
changing the classification of an organism, and it
should not be thought that one can make such a
change casually. I encourage the editors of
Emerging Infectious Diseases to seek the advice
of those who understand what should be done
with respect to the classification and nomencla-
ture of organisms.
William C. Marquardt
Colorado State University, Fort Collins,
Colorado, USA
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Reply to W.C. Marquardt: Dr. Marquardt’s
advocacy for reliance on morphologic characteris-
tics even if phylogenetic data become available
that lead to a different conclusion runs counter to
that expressed in an article he coauthored, which
supports the importance of molecular data (1).
The introduction of that paper states the
following:
“Early systematists relied largely on light
microscopic structures and life cycle patterns to
separate protozoa taxonomically....
Apicomplexans display enormous variations in
life cycle patterns, physiology, cytology, and
biochemistry.  There is no consensus on which
characteristics should be relied upon to infer
phylogenetic relationships.  Developmental and
ultrastructural features have been used to infer
evolutionary relationships among representative
genera in the class Sporozoea. However,
comparisons of phenotypic characters are
qualitative and lack objective quantitative
assessment to infer genetic relationships.
Sequence similarities between proteins or genes
which share a common evolutionary history can
be used to infer quantitative phylogenetic
relationships. The small subunit (16S-like)
rRNAs and their coding regions are especially
useful for estimating the extent of genetic
relatedness over broad evolutionary ranges.”
That paper concludes with the statement that
“ribosomal RNA sequence analyses of other
apicomplexans are required in order to test the
validity of relationships inferred from structures
and life cycle patterns.” Similarly, we concluded our
paper as follows: “Reports based on morphologic
features alone may suffer from poor resolution of
features needed for classification of closely related